Regenerative stem cell therapy offers new hope for treating cardiovascular disease

Nov 17, 2010

Northwestern Medicine physician researchers are revolutionizing treatment of cardiovascular disease by utilizing patients' own stem cells to regenerate heart and vascular tissue. Northwestern Medicine is the lead site for a study examining stem cell transplantation as treatment for critical limb ischemia. Chief investigator Douglas Losordo, MD, director of the Program in Cardiovascular Regenerative Medicine at Northwestern Memorial Hospital and the Eileen M. Foell Professor of Heart Research of Northwestern University's Feinberg School of Medicine, will present the findings of this study at the American Heart Association's Scientific Sessions in Chicago, on Wednesday, November 17.

"Traditionally, cardiovascular medicine has focused on repairing damaged tissues with medication or surgery," said Losordo, also director of the Feinberg Cardiovascular Research Institute. "For some patients, their cardiovascular disease is advanced to the point that standard treatment options are not effective. Regenerative cardiovascular medicine strives to redevelop cardiac and vascular tissue and stimulate new blood supply to areas like the heart and legs by using already present in the patient's body."

Losordo's limb preservation study examined the effectiveness of in limb preservation for patients with critical limb ischemia (CLI). CLI develops in patients with severe obstruction of the arteries which limits blood flow to the extremities. CLI results in more than 100,000 amputations annually in the United States. The trial tested the ability of CD34+ cells to stimulate new blood vessel formation in ischemic limbs, which can improve perfusion and salvage function.

The phase II, double-blind placebo controlled trial had a total of 28 patients randomized at 18 U.S. sites. The patients enrolled in this study were Rutherford class 4 and 5, meaning they were in the later stages of and at heightened risk for amputation. Patients in the randomized group had CD34 injected at eight locations in the ischemic limb and were followed for 12 months.

"Stem cell treatment was associated with a significant reduction in amputation rate," said Losordo. "Treatment was associated with a 50 percent reduction in the total amputation rate compared to control. Although further study is needed, these results provide evidence that CD34 cell therapy is an effective treatment for critical limb ischemia."

Losordo and his Northwestern Medicine team are leading the field of stem cell therapy for cardiovascular conditions and bringing it to the forefront of medicine. "The results of this study are encouraging and provide evidence for that stem cell therapy can significantly repair cardiac and vascular tissues," said Losordo. "As study of stem cells continues, I believe we're on the verge of a rebirth in the practice of medicine. Using a patient's own cells to regenerate their body has enormous potential to treat conditions that have previously been considered irreversible."

Explore further: Serotonin neuron subtypes: New insights could inform SIDS understanding, depression treatment

add to favorites email to friend print save as pdf

Related Stories

Your own stem cells can treat heart disease

Nov 17, 2009

The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in less pain and an improved ...

Researchers test stem cell therapy for heart patients

Oct 04, 2007

University of Florida doctors on Wednesday treated their first patient enrolled in a new study designed to test whether injecting stem cells into the heart helps restore blood flow to the organ by prompting new blood vessels ...

Cell transplantation and cardiac repair

Jul 01, 2009

The frontiers of cell transplantation for cardiac repair are discussed in the current issue of Cell Transplantation (Vol. 18 No.3), now available on-line.

Recommended for you

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

neiorah
not rated yet Nov 19, 2010
I am so encouraged by this because they do not have to use aborted embryo's for harvesting stem cells.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.